NCT00311727View on ClinicalTrials.gov

Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine

NACompletedINTERVENTIONAL
Enrollment

339

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza A/H5N1

232 subjects receive Influenza A/H5N1 vaccine as part of DMID protocols 04-063 and 04-076.

Trial Locations (3)

14642

University of Rochester, Rochester

21201

University of Maryland Baltimore, Baltimore

37232-2581

Vanderbilt University, Nashville

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00311727 - Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine | Biotech Hunter | Biotech Hunter